Crossmark

The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer

Crossref DOI link: https://doi.org/10.1038/s41598-022-12214-4

Published Online: 2022-05-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Catalano, Martina

Aprile, Giuseppe

Conca, Raffaele

Petrioli, Roberto

Ramello, Monica

Roviello, Giandomenico
License Information

Text and Data Mining valid from 2022-05-17

Version of Record valid from 2022-05-17
More Information

Article History

Received: 14 October 2021

Accepted: 27 April 2022

First Online: 17 May 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below